Talk to Experts: Consultative Page
Turn Your Protein Challenges into Your Next Breakthrough
In protein science, structure determines function—and every production decision you make shapes that structure. From the molecular chaperones in your chosen expression system to the buffer conditions during purification, each variable influences whether your recombinant protein maintains its native conformation and biological activity. The difference between a protein that merely exists and one that drives your program forward lies in understanding these fundamental structure-function relationships.
Why Your Protein Production Strategy Matters More Than You Think
Here’s a question that keeps many biologics leaders awake at night: What if the protein you’re producing today isn’t just a research tool—but the deciding factor in whether your program advances or stalls?
Every choice you make in protein production and characterization creates a ripple effect. The expression system you select. The purification approach you approve. The analytical package you specify. Each decision either accelerates your timeline toward IND or introduces delays that compound over months.
Let’s Talk About What You’re Really Facing
You’re not just looking for a protein production service. You’re navigating complex challenges that require scientific expertise:
- Does your current provider understand your protein class well enough to recommend the optimal expression system—or are they defaulting to their most familiar platform?
- Are you getting proteins with >95% purity and <1 EU/mg endotoxin levels that actually perform in your downstream assays, or just proteins that look good on a spec sheet?
- Is your characterization strategy generating decision-enabling data for your next development milestone, or just checking regulatory boxes?
- Can you scale your current approach when your program advances, or will you need to start over with a new provider?
Here’s How We’ve Helped Companies Like Yours
Over the past decades, we’ve delivered 1000+ purified recombinant proteins for companies facing exactly these challenges. Here’s what we’ve learned works:
For Production That Actually Accelerates Programs:
- We start by understanding your specific protein class and downstream requirements—then match you with the optimal expression system from our bacterial, yeast, insect, and mammalian platforms
- Your timeline matters: We deliver HEK293 proteins in 2 weeks and CHO systems in 2-3 weeks without compromising the quality standards you need
- Every protein undergoes rigorous characterization through SDS-PAGE, Western blot, mass spectrometry, and analytical HPLC/UPLC—because surprises slow programs down
For Characterization That Supports Confident Decisions:
- Our standard package (SDS-PAGE, Western blot, aSE-HPLC, intact mass analysis) gives you the baseline data every program needs
- When you need deeper insights, we provide specialized services: peptide mass fingerprinting, PTM analysis, SPR affinity studies, and stability analysis
- We structure all data with your regulatory pathway in mind—because the right characterization today prevents costly re-work later
Ready to Work with Scientists Who Get It?
When you connect with our Cell and Protein Sciences experts, you’re not just outsourcing production—you’re partnering with scientists who understand that your success depends on proteins that enable confident decisions.
What happens when you reach out:
- We listen first: Tell us about your protein, your timeline, and your biggest concerns. We’ll recommend the approach that makes sense for your specific situation
- We plan strategically: Whether you need rapid feasibility data or IND-ready materials, we’ll design a production and characterization strategy that fits your program’s current phase
- We solve problems together: When challenges emerge (and they always do), our team works with you to find solutions that keep your program moving forward
- We integrate seamlessly: Our approach connects smoothly with your downstream development activities—no handoff surprises
Your next breakthrough might be one conversation away.
